http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021524481-A

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-38
filingDate 2019-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2021524481-A
titleOfInvention Phenyl-N-quinoline derivative for treating RNA virus infection
abstract The present invention relates to RNA virus infections, particularly RNA virus infections derived from Group IV or Group V of the Baltimore classification, the compounds of formula (I) below, or pharmaceuticals thereof, for use in the treatment and / or prevention. With respect to any one of the allowed salts. [Chemical 1] Here, represents a chlorine atom or a hydrogen atom, and R represents an (C 1 to C 4 ) alkyl group, a (C 3 to C 6 ) cycloalkyl group, a halogen atom, and a (C 1 to C 5 ) alkoxy group. Represents -SO 2 -NR a R b group, -SO 3 H group, -OH group, -O-SO 2 -OR c group, or -OP (= O)-(OR c ) (OR d ) group. R 1 is (i) CF 3 groups, (ii) (C 1 to C 10 ) alkyl groups, (iii) (C 3 to C 6 ) cycloalkyl groups or (C 3 to C 6 ) heterocycloalkyl groups, Or (iv) represents a phenyl group or naphthyl, and R 2 is a hydrogen atom, (C 1 to C 10 ) alkyl group, (C 3 to C 6 ) cycloalkyl group or (C 3 to C 6 ) heterocyclo. Represents an alkyl group. The present invention further relates to novel compounds, pharmaceutical compositions containing them, and synthetic methods for producing them. [Selection diagram] None
priorityDate 2018-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ59149
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP70059
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35051
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO97399
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCD3ZQL7
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9VV43
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35050
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19799
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00775
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35049
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00764
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00761
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP23916
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ27957
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP24664
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466593948
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ7TQD2
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81071
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466666454
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO94811
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP51588
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465966785
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID89694343
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11341
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35048
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35034
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414867846
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP83348

Total number of triples: 49.